Captor Therapeutics Spolka Akcyjna Total Liabilities

Captor Therapeutics Spolka Akcyjna (CTX.WA) currently reports a total liabilities of $14M as of June 2026. That compares with $10M in the prior-year period — up 41.1% year over year. Use the charts on this page to explore Captor Therapeutics Spolka Akcyjna's total liabilities history and peer comparisons.

Captor Therapeutics Spolka Akcyjna's total liabilities increased from $10M to $14M — a 41.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Captor Therapeutics Spolka Akcyjna reported $14M in total liabilities as of June 2026. That compares with $10M in the prior-year period — up 41.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Captor Therapeutics Spolka Akcyjna, and consider following CTX.WA for alerts when major investors trade the stock.

Captor Therapeutics Spolka Akcyjna is classified in the Healthcare sector. On total liabilities, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTX.WA with unrelated industries.